Bioprospecting for HIV-1 latency reversing agent (prostratin) from indigenous medicinal plants for latency reversal in HIV-1 subtypes A and D in Uganda (HIV-1_AD_LRA study)-PHASE-3
Joseph Francis Hokello
Components
Scientific Component – Isolation of resting memory CD4+ T cells, efficacy testing, phytochemical profiling. Collaborative Component – Partnerships with TASO Entebbe, UVRI, DGAL, and Busitema University. Capacity Building – Training graduate fellows and strengthening research infrastructure. Innovation Component – Advancement of PROVIRID as a potential HIV cure candidate.